Are you able to elaborate a little on bisantrene "behaved the same way" as gene knockdown?
Does that refer to the shape of the graph of reaction rate (y) to drug concentration (x)? And if so, how does one measure "concentration" of gene knockdown?
Please feel free to respond with just a link or an external reference if that's more convenient than correcting my misconceptions in writing.
Thank you for the ongoing Biotech Investment 101 course. My lecture notes are almost 100 pages now.
Pillar 1 - FTO (new thread), page-434
-
- There are more pages in this discussion • 2,558 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.165(11.5%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.61 | $1.46 | $245.3K | 161.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 229 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 1226 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |